Emergent BioSolutions Inc Sustainability Reports
Emergent BioSolutions Inc. is a global life sciences company that develops and manufactures specialty products, vaccines, and antibody therapeutics designed to address public health threats and medical countermeasures. Its commercial offerings include products for opioid overdose reversal and biodefense protections against pathogens such as anthrax and smallpox.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 549300YW6TUOX8BE5103
FIGI: BBG001SP1G40
20 reports from 2008 to 2025
